1 Min Read
Oct 10 (Reuters) - LBT Innovations Ltd
* Clever culture systems received clearance of its 510(k) de novo submission to US FDA for APAS as a class II medical device. Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.